Skip to main content
SpringerLink
Log in

Tumoren der Prostata

  • Chapter
Atlas der Pathologie urologischer Tumoren

  • 32 Accesses

Zusammenfassung

Bei ausgewachsenen jungen Männern wiegt die Prostata ca. 30 g und weist einen sagittalen Durchmesser bis 2,5 cm auf. Nach abgeschlossener spezifischer Differenzierung unter Andro-geneinfluß finden sich 30–50 Drüsenläppchen mit etwa 15–30 Ausführungsgängen. Diese münden in die Furchen seitlich des Colliculus seminalis ein. Die überwiegende Organmasse wird durch die Außendrüse gebildet. Diese umschließt die sogenannte Innendrüse, die durch eine fibromuskuläre Zone abgegrenzt ist. Das Gesamtorgan ist von einer kapsei- oder bandartigen Muskel- und Bindegewebsschicht umgeben mit Gefäßen und Nerveneinschlüssen, die als sog. Prostatakapsel in der TNM-Klassifikation geführt wird (Ayala et al. 1989).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abrahamsson PA, Wadström LB, Alumets J, Falkmer St, Grimelius L (1987) Peptidehormone-und serotonin-immuno reactive tumour cells in carcinomata of the prostate. Pathol Res Pract 182: 298–307

    PubMed  CAS  Google Scholar 

  • Al-Abadi H, Nagel R (1988) Prognostische Bedeutung von Ploidie und proliferativer Aktivität beim lokal fortgeschrittenen Prostatakarzinom. Aktuel Urol 19: 182–186

    Google Scholar 

  • Al-Abadi H, Nagel R (1990) Nuclear DNA analysis: The relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years. Urol Int 45: 350–355

    CAS  Google Scholar 

  • Allsbrook WC, Simms WW (1992) Histochemistry of the prostate. Hum Pathol 23: 297–305

    PubMed  Google Scholar 

  • Altwein JE, Faul P (1990) Probleme und Prinzipien der Hormontherapie des fortgeschrittenen Prostatakarzinoms. Klin Wochenschr 68: 347–358

    PubMed  CAS  Google Scholar 

  • Anichkov N (1991) Neuroendocrine cells (NEC) in normal and neoplastic epithelial structures of urethra. Pathol Res Pract 187: 650

    Google Scholar 

  • Aumüller G (1989) Morphologic and regulatory aspects of prostatic function. Anat Embryol 179: 519–531

    PubMed  Google Scholar 

  • Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ (1989) The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 13: 21–27

    PubMed  CAS  Google Scholar 

  • Babaian RJ, Troncoso P, Ayala A (1991) Transurethral-resection zone prostate cancer detected at cystoprostatectomy. A detailed histologic analysis and clinical implications. Cancer 67: 1418–1422

    PubMed  CAS  Google Scholar 

  • Badalament RA, O’Toole RV, Young DC, Drago JR (1991) DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Cancer 67: 3014–3023

    PubMed  CAS  Google Scholar 

  • Bibbo M, Kim DH, Galera-Davidson H, Di Loreto C, Dytch HE (1990 a) Architectural morphometric and photometric features and their relationship to the main subjective diagnostic clues in the grading of prostatic cancer. Anal Quant Cytol Histol 12: 85–90

    PubMed  CAS  Google Scholar 

  • Bibbo M, Kim DH, Pfeifer T, Dytch HE, Galera-Davidson H, Bartels PH (1990b) Histometric features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 13: 61–68

    Google Scholar 

  • Bibbo M, Kim DH, Di Loreto C et al. (1990c) Tissue architectural features for the grading of prostatic carcinoma. Anal Quant Cytol Histol 12: 229–236

    PubMed  CAS  Google Scholar 

  • Böcking A (1990) DNA-Zytometrie und Automation in der klinischen Diagnostik. Beitr Onkol 38: 298–347

    Google Scholar 

  • Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M (1989) Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63: 1714–1720

    PubMed  CAS  Google Scholar 

  • Bonkhoff H, Wernert N, Remberger K, Dhom G (1989) Topographische Lagebeziehung zwischen endokrin differenzierten Zellen und der Proliferationsfraktion in Prostatakarzinomen. Verh Dtsch Ges Pathol 73: 638

    Google Scholar 

  • Bonkhoff H, Wernert N, Dhom G, Remberger K (1991) Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate. Virchows Archiv [A] 418: 375–381

    CAS  Google Scholar 

  • Bonkhoff H, Remberger K (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch [A] 422: 35–38

    CAS  Google Scholar 

  • Bonkhoff H, Wernert N, Dhom G, Remberger K (1992) Distribution of basement membranes in primary and metastatic carcinomas of the prostate. Hum Pathol 23: 934–939

    PubMed  CAS  Google Scholar 

  • Bostwick DG, Brawer MK (1987) Prostatic intraepithelial neoplasia and early invasion in prostatic cancer. Cancer 59: 788–794

    PubMed  CAS  Google Scholar 

  • Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP (1992) The association of benign prostatic hyperplasia and cancer of prostate. Cancer 70: 291–301

    PubMed  CAS  Google Scholar 

  • Botticelli AR, Criscuolo M, Martinelli AM (1991) Prostatic value of AgNOR in prostatic carcinomas. Pathol Res Pract187: 661

    Google Scholar 

  • Brawer MK (1992) Prostatic intraepithelial neoplasia: a premalignant lesion. Hum Pathol 23: 242–248

    PubMed  CAS  Google Scholar 

  • Brawer MK, Pechl DM, Stamey TA, Bostwick DG (1985) Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45: 3663–3667

    PubMed  CAS  Google Scholar 

  • Brawer MK, Rennels MA, Nagle RB, Soiderer MH, Lee F (1989 a) Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound. J Urol 142: 1510–1512

    PubMed  CAS  Google Scholar 

  • Brawer MK, Nagle RB, Pitts W, Freiha F, Gamble SL (1989b) Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates. Cancer 63: 454–460

    PubMed  CAS  Google Scholar 

  • Brawn PN (1982) Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 49: 826–833

    PubMed  CAS  Google Scholar 

  • Brawn PN (1992) Histologic features of metastatic prostate cancer. Hum Pathol 23: 267–272

    PubMed  CAS  Google Scholar 

  • Brawn PN, Speights VO (1989) The dedifferentiation of metastatic prostate carcinoma. Br J Cancer 59: 85–88

    PubMed  CAS  Google Scholar 

  • Brawn PN, Speights VO, Contin JU, Bayardo RJ, Kuhl DL (1989) Atypical hyperplasia in prostates of 2010-year-old men. J Clin Pathol 42: 383–386

    PubMed  CAS  Google Scholar 

  • Brawn PN, Kuhl D, Johnson C, Pandya P, Mc Cord R (1990) Stage DI prostate carcinoma. The histologic appearance of nodal metastases and its relationship to survival. Cancer 65: 538–543

    PubMed  CAS  Google Scholar 

  • Carter BS, Epstein JI, Isaacs, WB (1990) Ras gene mutations in human prostate cancer. Cancer Res 50: 6830–6832

    PubMed  CAS  Google Scholar 

  • Casiraghi O, Martinez-Madrigal F, Mostofi FK, Micheau C, Caillou B, Tursz T (1991) Primary prostatic Wilms’ tumor. Am J Surg Pathol 15: 885–890

    PubMed  CAS  Google Scholar 

  • Chen KTK, Schiff JJ (1983) Adenomatoid prostatic tumor. Urology 21: 88–89

    PubMed  CAS  Google Scholar 

  • Christensen WN, Partin AW, Walsh PC, Epstein JI (1990) Pathologic findings in clinical stage A2 prostate cancer. Cancer 65:1021–1027

    PubMed  CAS  Google Scholar 

  • Christensen WN, Steinberg G, Walsh PC, Epstein JI (1991) Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer 67: 2118–2124

    PubMed  CAS  Google Scholar 

  • Cohen RJ, Glezerson G, Haffejee Z, Afrika D (1990) Prostatic carcinoma. Histological and immunohistological factors affecting prognosis. Br J Urol 66: 405–410

    PubMed  CAS  Google Scholar 

  • Cohen RJ, Glezerson G, Hattejee Z (1991) Neuroendocrine cells -a new prognostic parameter in prostatic cancer. Br J Urol 68: 258–262

    PubMed  CAS  Google Scholar 

  • Collina G, Botticelli AR, Martinelli AM, Fano RA, Trentini GP (1992) Sclerosing adenosis of the prostate. Report of three cases with electronmicroscopy and immunohistochemical study. Histopathology 20: 505–510

    PubMed  CAS  Google Scholar 

  • Contractor H, Rüschoff J, Hanisch T, Ulshöfer B, Neumann K, Schultze-Seemann W, Thomas C (1991) Silver-stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis. Urol Int 46: 9–14

    PubMed  CAS  Google Scholar 

  • Davis BE, Weigel JW (1990) Adenocarcinoma of the prostate discovered in 2 young patients following total prostato vesiculectomy for refractory prostatitis. J Urol 144: 744–745

    PubMed  CAS  Google Scholar 

  • Dawson NA, Wilding G, Weiss RB et al. (1992) A pilot trial of chemohormonal therapy for metastatic prostate carcinoma. Cancer 69: 213–218

    PubMed  CAS  Google Scholar 

  • Denholm SW, Webb JN, Howard CCW, Chisholm GD (1992) Basaloid carcinoma of the prostate gland: histogenesis and review of the literature. Histopathol 20: 151–155

    CAS  Google Scholar 

  • Deschenes J, Weidner N (1990) Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease. Am J Surg Pathol 14: 1148–1155

    PubMed  CAS  Google Scholar 

  • Deusel A, Kaduk B, May P (1991) Fall einer äußerst seltenen Organmetastasierung eines Prostatakarzinoms. Urologe B 31:224–225

    Google Scholar 

  • Devaney DM, Dorman A, Leader M (1991) Adenoquamous carcinoma of the prostate. A case report. Hum Pathol 22: 1046–1050

    CAS  Google Scholar 

  • Dhom G (1990) Unusual prostatic carcinomas. Pathol Res Pract 186: 28–36

    PubMed  CAS  Google Scholar 

  • Dhom G (1991) Prostata. In: Doerr W, Seifert G (Hrsg) Pathologie des männlichen Genitale. Spezielle pathologische Anatomie, Bd 21. Springer, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona, S 455–642

    Google Scholar 

  • Dhom G, Degro S (1982) Therapy of prostatic cancer and histopathologic follow-up. The Prostate 3: 531–542

    PubMed  CAS  Google Scholar 

  • Dundas GS, Porter AT, Venner PM (1990) Prostate specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker. Cancer 66: 45–48

    PubMed  CAS  Google Scholar 

  • Dupont A, Cusan L, Gomez JL, Thibeault MM, Tremblay M, Labrie F (1991) Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate. J Urol 146: 1064–1068

    PubMed  CAS  Google Scholar 

  • Epstein JI (1990) Evaluation of radical prostatectomy capsular margins of resection -the significance of margins designated as negative, closely approaching, and positive. Am J Surg Pathol 14: 626–632

    PubMed  CAS  Google Scholar 

  • Epstein JI, Steinberg GD (1990) The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume and stage of the biopsied and multifocal tumor. Cancer 66: 1927–1932

    PubMed  CAS  Google Scholar 

  • Epstein JI, Cho KR, Quinn BD (1990) Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65:2321–2327

    PubMed  CAS  Google Scholar 

  • Falkmer UG (1992) Methodologie sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma. Hum Pathol 23: 360–367

    PubMed  CAS  Google Scholar 

  • Falkmer S, Askensten U, Grimelius L, Abrahamsson PA (1990) Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression. Acta Histochem (Jena) [Suppl] 38:127–132

    CAS  Google Scholar 

  • Faul P, Partecke G (1989) Klinische Bedeutung und Problemstellung des inzidentellen Prostatakarzinoms. Aktuel Urol 20: 1–8

    Google Scholar 

  • Fetissof F, Bruandet P, Arbeille B et al. (1986) Calcitonin-secreting carcinomas of the prostate. An immunohistochemical and ultrastructural analysis. Am J Surg Pathol 10: 702–710

    PubMed  CAS  Google Scholar 

  • Forsslund G, Esposti PL, Nilsson B, Zetterberg A (1992) The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer 69: 1432–1439

    PubMed  CAS  Google Scholar 

  • Funa K, Nordgren H, Nilsson S (1991) In situ expression of mRNA for protooncogenes in benign prostatic hyperplasia and in prostatic carcinoma. Scand J Urol Nephrol 25: 95–100

    PubMed  CAS  Google Scholar 

  • Gaffney EF, O’Sullivan SN, O’Brien A (1992) A major solid undifferentiated carcinoma pattern correlates with tumour progression in locally advanced prostatic carcinoma. Histopathology 21: 249–255

    PubMed  CAS  Google Scholar 

  • Gallee MPW, Visser-De Jong E, Ten Kate FJW, Schroeder FH, Kwast TH van der (1989) Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J Urol 142: 1342–1346

    PubMed  CAS  Google Scholar 

  • Gallee MPW, Ten Kate FJW, Mulder PGH. Blom JHM. Heul RO van der (1990) Histological grading of prostatic carcinoma in prostatectomy specimens. Comparison of prognostic accuracy of five grading systems. Br J Urol 65: 368–375

    PubMed  CAS  Google Scholar 

  • Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother 50: 125–130

    CAS  Google Scholar 

  • Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23: 273–279

    PubMed  CAS  Google Scholar 

  • Green LK, Klima M (1991) The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast. Hum Pathol 22: 242–246

    PubMed  CAS  Google Scholar 

  • Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR (1988) Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland. An immunohisto-chemical study. Hum Pathol 19: 1425–1433

    PubMed  CAS  Google Scholar 

  • Haapiainen RK, Permi EJ, Rannikko SAS, Voutilainen PEJ. Liewendahl K, Stenman UH, Alfthan OS (1990) Prostate tumour markers as an aid in the staging of prostatic cancer. Br J Urol 65: 264–267

    PubMed  CAS  Google Scholar 

  • Habib FK, Bissas A, Neill WA, Busuttil A, Chisholm GD (1989) Flow cyometric analysis of cellular DNA in human prostate cancer: relationship to 5-Alpha-reductase activity of the tissue. Urol Res 17: 239–243

    PubMed  CAS  Google Scholar 

  • Hagood PG, Johnson FE, Bedrossian CWM, Silverberg AB (1991) Small cell carcinoma of the prostate. Cancer 67: 1046–1050

    PubMed  CAS  Google Scholar 

  • Hansen AB, Ostergard B (1990) Nucleolar organizer regions in hyperplastic and neoplastic prostatic tissue. Virchows Archiv [A] 417: 9–13

    CAS  Google Scholar 

  • Hardeman SW, Soloway MS (1988) Transitional cell carcinoma of the prostate: diagnosis, staging and management. World J Urol 6: 170–174

    Google Scholar 

  • Harrison SH, Seale-Hawkins C, Schum CW, Dunn JK, Scardino PT (1992) Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer. Cancer 69: 750–754

    PubMed  CAS  Google Scholar 

  • Hedrick L, Epstein JI (1989) Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol 13: 389–396

    PubMed  CAS  Google Scholar 

  • Helpap B (1981) Cell kinetic and cytological grading of prostatic carcinoma. Virchows Arch [A] 393: 205–214

    CAS  Google Scholar 

  • Helpap B (1988) Frequency and localization of nucleoli in nuclei from prostatic carcinoma and atypical hyperplasia. Histopathology 12: 203–211

    Google Scholar 

  • Helpap B (1989) Pathologie der ableitenden Harnwege und der Prostata. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Helpap B (1991 a) Atypical hyperplasia, intraepithelial neoplasia and incidental carcinoma of the prostate. In: Altwein JE, Faul P, Schneider W (eds) Incidental carcinoma of the prostate. Springer, Berlin Heidelberg New York Tokyo, S 74–91

    Google Scholar 

  • Helpap B (1991b) Morphologie des Prostatakarzinoms; Histopathologie. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 11–42

    Google Scholar 

  • Helpap B (1992 a) Grading and prognostic significance of urologic carcinomas. Urol Int 48: 245–257

    PubMed  CAS  Google Scholar 

  • Helpap B (1992 b) Pathologie der chronischen unspezifischen Prostatitis. In: Vahlensieck W, Rutishauser G (Hrsg) Benigne Prostatopathien. Thieme, Stuttgart New York, 35–50

    Google Scholar 

  • Helpap B, Koch V (1991) Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy. J Cancer Res Clin Oncol 117: 608–614

    PubMed  CAS  Google Scholar 

  • Helpap B, Böcking A, Dhom G, Kastendieck H, Leistenschneider W, Müller HA (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Eine Empfehlung des pathologisch-urologischen Arbeitskreises “Prostatakarzinom”. Pathologe 6: 3–7

    PubMed  CAS  Google Scholar 

  • Helpap B, Oehler U, Bollmann R (1990) Das endokrin differenzierte Prostatakarzinom. Histologie und Immunhistochemie. Pathologe 11: 18–24

    PubMed  CAS  Google Scholar 

  • Hermanek P, Sobin LH (1987/1992) TNM classification of malignant tumours. Springer, Berlin Heidelberg New York Tokyo (4th rev. edn. 1987/4th edn., 2nd rev. 1992)

    Google Scholar 

  • Hesse A, Neumann K, Thomas C (1990) Immunreaktivität von Prostata-und Harnblasenkarzinomen. Tumor Diagnostik & Therapie 11: 29–32

    Google Scholar 

  • Honig SC, Stilmant MM, Klavans MS, Freedlund MC, Siroky MB (1992) The role of fine-needle aspiration biopsy of the prostate in staging adenocarcinoma. Cancer 69: 2978–2982

    PubMed  CAS  Google Scholar 

  • Huland H (1991) Morphologische Grundlagen zur radikalen Prostatektomie. Urologe [A] 30: 361–369

    CAS  Google Scholar 

  • Hulman G (1989) “Pseudoadenomatoid” tumour of prostate. Histopathology 14: 317–323

    PubMed  CAS  Google Scholar 

  • Hulse CA, O’Neill T (1989) Adenocarcinoma of the prostate metastatic to the ureter with an associated ureteral stone. J Urol 142:1312–1313

    PubMed  CAS  Google Scholar 

  • Humphrey PA, Walther PJ, Currin SM, Vollmer RT (1991) Histologic grade, DNA ploidy and intraglandular tumor extent as indicators of tumor progression of clinical stage B prostatic carcinoma. A direct comparison. Am J Surg Pathol 15:1165–1170

    PubMed  CAS  Google Scholar 

  • Idikio HA, Manickavel V (1991) Correlation of blood group antigen expression and oncogene-related proteins in malignant prostatic tussues. Pathol Res Pract 187: 189–197

    PubMed  CAS  Google Scholar 

  • Jones EC, McNeal J, Bruchovsky N, Jong G de (1990) DNA content in prostatic adenocarcinoma. Cancer 66: 752–757

    PubMed  CAS  Google Scholar 

  • Jones EC, Clement PB, Young RH (1991) Sclerosing adenosis of the prostate gland. Am J Surg Pathol 15: 1171–1180

    PubMed  CAS  Google Scholar 

  • Jones H, Anthony PP (1992) Metastatic prostatic carcinoma presenting as left-sided cervical lymphadenopathy: a series of 11 cases. Histopathology 21:149–154

    PubMed  CAS  Google Scholar 

  • Kabalin JN, McNeal ME, Price HM, Freiha FS, Stamey TA (1989) Unsuspected adenocarcinoma of the prostate in patients undergoing cytoprostatectomy for other causes. Incidence, histology and morphometric observations. J Urol 141: 1091–1094

    PubMed  CAS  Google Scholar 

  • Kaplan ID, Prestidge BR, Cox RS, Bagshaw MA (1990) Prostate specific antigen after irradiation for prostatic carcinoma. J Urol 144:1172–1176

    PubMed  CAS  Google Scholar 

  • Kaplan ID, Cox RS, Bagshaw MA (1991) A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy. Cancer 68: 400–405

    PubMed  CAS  Google Scholar 

  • Kelemen PR, Buschmann RJ, Weisz-Carrington P (1990) Nucleolar prominence as a diagnostic variable in prostatic carcinoma. Cancer 65:1017–1020

    PubMed  CAS  Google Scholar 

  • Kernion de JB, Neuwirth H, Stein A, Dorey F, Stenzl A, Hannah J, Blyth B (1990) Prognosis of patients with stage Dl prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J Urol 144: 700–703

    Google Scholar 

  • Klein EA (1990) Die Genetik urologischer Tumoren. Teil 1. Zytogenetische und molekularbiologische Grundlagen. AktuelUrol 21: 303–311

    Google Scholar 

  • Klein EA (1991) Die Genetik urologischer Tumoren. Teil 2. Klassische und zytogenetische Konzepte der Karzinomgenese und chromosomale Aberrationen bei speziellen urologischen Tumoren. Aktuel Urol 22: 1–9

    Google Scholar 

  • Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM (1992) K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer 69: 2293–2299

    PubMed  CAS  Google Scholar 

  • Kuban DA, El-Mahdi AM, Schellhammer PF (1989a) Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer 63: 2421–2425

    PubMed  CAS  Google Scholar 

  • Kuban DA, El-Mahdi AM, Schellhammer PF (1989b) 1-125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer 63: 2415–2420

    PubMed  CAS  Google Scholar 

  • Larsen MP, Carter HB, Epstein JI (1991) Can stage Al tumor extent be predicted by transurethral resetion tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 146:1059–1063

    PubMed  CAS  Google Scholar 

  • Lee F, Siders DB, Torp-Pedersen ST, Kirscht JL, Mc Hugh TA, Mitchell AE (1991) Prostate cancer. Transrectal ultrasound and pathology comparison. A preliminary study of outer gland (peripheral and central zones) and inner gland (transition zone) cancer. Cancer 67: 1132–1142

    PubMed  CAS  Google Scholar 

  • Lerner SP, Seale-Hawkins C, Carlton CE, Scardino PT (1991) The risk of dying of prostate cancer in patients with clinically localized disease. J Urol 146: 1040–1045

    PubMed  CAS  Google Scholar 

  • Löbelenz M, Pfiester P, Potempa D, Rassweiler J, Aiken P (1989) Malignes Schwannom der Prostata. Aktuel Urol 20: 345–347

    Google Scholar 

  • Loughlin KR, Retik AB, Weinstein HJ, Colodny AH, Sham-berger RC, Delorey M, Tarbell N (1989) Genitourinary rhabdomyosarcoma in children. Cancer 63: 1600–1606

    PubMed  CAS  Google Scholar 

  • McNeal JE (1988 a) Normal histology of the prostate. Am J Surg Pathol 12: 619–633

    PubMed  CAS  Google Scholar 

  • McNeal JE (1988 b) Significance of duct-acinar dysplasia in prostatic carcinogenesis. The Prostate 13: 91–102

    PubMed  CAS  Google Scholar 

  • McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread. Hum Pathol 23: 258–266

    PubMed  CAS  Google Scholar 

  • McNeal JE, Bostwick DG (1986) Intraductal dysplasia. A premalignant lesion of the prostate. Hum Pathol 17: 64–71

    PubMed  CAS  Google Scholar 

  • McNeal JE, Redwine EA, Freiha FS, Stamey TA (1988) Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12/12: 897–906

    PubMed  CAS  Google Scholar 

  • McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA (1990) Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66:1225–1233

    PubMed  CAS  Google Scholar 

  • McNeal JE, Alroy J, Villers A, Redwine EA, Freiha FS, Stamey TA (1991 a) Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol 22: 979–988

    PubMed  CAS  Google Scholar 

  • McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA (1991b) Microcarcinoma in the prostate. Its association with duct-acinar dysplasia. Hum Pathol 22: 644–652

    PubMed  CAS  Google Scholar 

  • Meister P, Heidi G (1991) Postoperativer Spindelzellknoten der Harnblase und Prostata. Pathologe 12: 214–219

    PubMed  CAS  Google Scholar 

  • Mohler JL, Partin AW, Epstein JI et al. (1992) Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer 69: 511–519

    PubMed  CAS  Google Scholar 

  • Moldwin RM, Orihuela E (1989) Breast masses associated with adenocarcinoma of the prostate. Cancer 63: 2229–2233

    PubMed  CAS  Google Scholar 

  • Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM (1990) Stage B prostate adenocarcinoma -flow cytometric nuclear DNA ploidy analyses. Arch Surg 125: 327–331

    PubMed  CAS  Google Scholar 

  • Montie JE, Wood DP, Pontes JE, Boyett JM, Levin HS (1989) Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 63: 381–385

    PubMed  CAS  Google Scholar 

  • Montironi R, Scarpelli M, Sisti S, Braccischi A. Mariuzzi GM (1990 a) Morphological and quantitative analyses of intraductal dysplasia of the prostate. Anal Cell Pathol 2: 277–285

    PubMed  CAS  Google Scholar 

  • Montironi R. Scarpelli M, Sisti S, Braccischi A, Gusella P, Alberti R, Mariuzzi GM (1990b) Cytometric evaluation of the intraepithelial neoplasia of the prostate gland. Ann NY Acad Sei 595: 403–405

    Google Scholar 

  • Montironi R, Braccischi A. Matera G, Scarpelli M. Pisani E (1991) Quantitation of the prostatic intraepithelial neoplasia. Analysis of the nucleolar size, number and location. Pathol Res Pract 187: 307–314

    PubMed  CAS  Google Scholar 

  • Mostofi FK, Sesterhenn IA, Sobin LH (1980) Histological typing of prostate tumours. International histological classification of tumours. No 22. World Health Organisation, Geneva

    Google Scholar 

  • Mostofi FK, Sesterhenn IA, Davies CJ (1992 a) Prostatic carcinoma: Problems in the interpretation of prostatic biopsies. Hum Pathol 23: 223–241

    PubMed  CAS  Google Scholar 

  • Mostofi FK, Davies CJ, Sesterhenn IA (1992b) Pathology of carcinoma of the prostate. Cancer [suppl] 70: 235–253

    PubMed  CAS  Google Scholar 

  • Moul JW, Paulson DF, Fuller G, Gottfried MR, Floyd WL (1989) Prostate cancer with solitary parotid metastasis correctly diagnosed with immunohistochemical stains. J Urol 142: 1328–1329

    PubMed  CAS  Google Scholar 

  • Müller HA, Altenähr E, Böcking A et al. (1980) Über Klassifikation und Grading des Prostatakarzinoms. Verh Dtsch Ges Pathol 64: 609–611

    Google Scholar 

  • Mulders PFA, Dijkman GA, del Moral PF, Theeuwes AGM, Debruyne FMJ et al. (1990) Analysis of prognostic factors in disseminated prostatic cancer. An update. Cancer 65: 2758–2761

    PubMed  CAS  Google Scholar 

  • Nagle RB, Brawer MK, Kittelson J, Clark V (1991) Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138: 119–128

    PubMed  CAS  Google Scholar 

  • Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM (1990) Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol 144: 303–306

    PubMed  CAS  Google Scholar 

  • Nazeer T, Barada JH, Fischer HAG. Ross JS (1991) Prostatic carcinosarcoma: case report and review of literature. J Urol 146: 1370–1373

    PubMed  CAS  Google Scholar 

  • Nemoto R, Hattori K, Uchida K, Shimazui T, Nishijima Y, Koiso K, Harada M (1990) S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxy-uridine labeling. Cancer 66: 509–514

    PubMed  CAS  Google Scholar 

  • Nusko G, Löhr M, Hahn EG (1992) Genetische Veränderungen in der Pathogenese maligner Erkrankungen. Klinikarzt 21: 76–81

    Google Scholar 

  • Okada H, Tsubura A, Okamura A, Senzaki H, Naka J, Komatz J, Moni S (1992) Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch [A] 421: 157–161

    CAS  Google Scholar 

  • O’Malley FP, Grignon DJ, Shum DT (1990) Usefulness of immunoperoxidase staining with high-molecular-weight cyto-keratin in the differential diagnosis of small-acinar lesions of the prostate gland. Virchows Archiv [A] 417: 191–196

    Google Scholar 

  • Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI (1992) Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 70: 161–168

    PubMed  CAS  Google Scholar 

  • Perlman EJ, Epstein JI (1990) Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 14: 810–818

    PubMed  CAS  Google Scholar 

  • Perrapato SD, Shah PC. Huben RP, Gaeta JF (1991) Locally recurrent endometrioid adenocarcinoma of the prostate after radical prostatectomy. J Urol 145: 373–375

    PubMed  CAS  Google Scholar 

  • Pinder SE, McMahon RFT (1990) Mucins in prostatic carcinoma. Histopathology 16: 43–46

    PubMed  CAS  Google Scholar 

  • Pienkos EJ, Meisner LF (1991) Adenocarcinoma of the prostate in A 41-year-old man with xxy karyotype and chronic lymphocytic leukemia. Report of a case. J Urol 145: 148–150

    PubMed  CAS  Google Scholar 

  • Quinn BD, Cho KR, Epstein JI (1990) Relationship of servere dysplasia to stage B adenocarcinoma of the prostate. Cancer 65: 2328–2337

    PubMed  CAS  Google Scholar 

  • Rackley RR, Yang B, Pretlow TG et al. (1991) Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia. Cancer 68: 587–593

    PubMed  CAS  Google Scholar 

  • Ro JY. El-Naggar A, Ayala AG, Mody DR, Ordonez NG (1988) Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 12: 453–460

    PubMed  CAS  Google Scholar 

  • Ro JY, Grignon DJ, Ayala AG, Fernandez PL, Ordonez NG, Wishnow KI (1990) Mucinous adenocarcinoma of the prostate. Histochemical and immunohistochemical studies. Hum Pathol 21: 593–600

    PubMed  CAS  Google Scholar 

  • Rojas-Corona RR, Chen L, Mahadevia PS (1987) Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances. Am J Clin Pathol 88: 759–762

    PubMed  CAS  Google Scholar 

  • Ronnett BM, Epstein JI (1989) A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate. Am J Surg Pathol 13: 866–872

    PubMed  CAS  Google Scholar 

  • Ruizeveld de Winter JA, Trapman J et al. (1990) Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 161: 329–332

    Google Scholar 

  • Russell KJ, Dunatov C, Hafermann MD et al. (1991) Prostate specific antigen in the management of patients with localized adenocarcinoma of the protate treated with primary radiation therapy. J Urol 146: 1046–1052

    PubMed  CAS  Google Scholar 

  • Sadi MV, Barrack ER (1991) Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapy. Cancer 67: 3065–3071

    PubMed  CAS  Google Scholar 

  • Sadi MV, Walsh PC, Barrack ER (1991) Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer 67: 3057–3064

    PubMed  CAS  Google Scholar 

  • Sant’ Agnese PA (1988) Neuroendocrine differentiation and prostatic carcinoma. The concept “comes of age”. Arch Pathol Lab Med 112: 1097–1099

    Google Scholar 

  • Sant’Agnese PA (1992a) Neuroendocrine differentiation in human prostatic carcinoma. Human Pathol 23: 287–296

    Google Scholar 

  • Sant’Agnese PA (1992b) Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer [suppl] 70: 254–268

    Google Scholar 

  • Sar M, Lubahn DB, French FS, Wilson EM (1990) Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127: 3180–3186

    PubMed  CAS  Google Scholar 

  • Sakamoto N, Tsuneyoshi M, Enjoji M (1991) Sklerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis. Am J Surg Pathol 15: 660–667

    PubMed  CAS  Google Scholar 

  • Schellhammer PF (1991) Local failure and related complications after definitive treatment of clinical stage C carcinoma of the prostate by irradiation or surgery. Semin Urol 4: 232–246

    Google Scholar 

  • Schmid HP, McNeal JE (1992) An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol 16: 184–191

    PubMed  CAS  Google Scholar 

  • Scrivner DL, Meyer JS, Rujanavech MN, Fathman A, Scully T (1991) Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J Urol 146: 1034–1039

    PubMed  CAS  Google Scholar 

  • Scully MF, Uno JM, Mclntyre M, Mosely S (1990) Radiation-induced prostatic sarcoma. A case report. J Urol 144: 746–748

    PubMed  CAS  Google Scholar 

  • Sesterhenn IA, Becker RL, Avallone FA, Mostofi FK, Lin TH, Davis jr CJ (1991) Image analysis of nucleoli and nucleolar organizer regions in prostatic hyperplasia, intraepithelial neoplasia and prostatic carcinoma. Urogenit Pathol 1: 61–75

    Google Scholar 

  • Shinohara K, Wheeler TM, Scardino PT (1989) The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol 142: 76–82

    PubMed  CAS  Google Scholar 

  • Srigley JR, Dardick I, Warren R, Hartwick J, Klotz L (1990) Basal epithelial cells of human prostate gland are not myoepithelial cells: a comparative immunohistochemical and ultrastructural study with the human salivary gland. Am J Pathol 136: 957–966

    PubMed  CAS  Google Scholar 

  • Stamey TA (1990) Die Rolle des prostataspezifischen Antigens bei der Diagnose und Behandlung des Prostataadenokarzinoms. Urologe A 29: 52–64

    PubMed  CAS  Google Scholar 

  • Stamey TA (1991) Prostatakarzinom -Klinische und morphometrische Grundlagen. Urologe A 30: 348–360

    PubMed  CAS  Google Scholar 

  • Stiens R, Helpap B, Weißbach L (1981) Quantitative Untersuchungen zum Zellverlust in Prostatacarcinomen. Klinischmorphologische Aspekte. Verh Dtsch Ges Urol 32: 73–74

    Google Scholar 

  • Suzuki H, Nakada T, Iijima Y, Kaneko H, Suzuki Y, Ishii N, Onmura Y (1991) Malignant lymphoma of the prostate: report of a case. Urol Int 47: 172–175

    PubMed  CAS  Google Scholar 

  • Svanholm H, Starklint H, Barlebo H, Olsen S (1989) Histological evaluation of prostatic cancer. (I) Reproducibility of tumour type. APMIS 97: 699–704

    PubMed  CAS  Google Scholar 

  • Svanholm H, Starklint H, Barlebo H. Olsen S (1990 a) Histological evaluation of prostatic cancer (II): Reproducibility of a histological grading system. APMIS 98: 229–236

    PubMed  CAS  Google Scholar 

  • Svanholm H, Starklint H, Barlebo H, Olsen S (1990b) Histological evaluation of prostatic cancer (III): Reproducibility of assessment of tumor volume and its possible significance for prognosis. APMIS 98: 237–243

    PubMed  CAS  Google Scholar 

  • Tribukait B (1987) Flow cytometry in assessing the clinical agressiveness of genitourinary neoplasms. World J Urol 5: 108–122

    Google Scholar 

  • Voges G, Hohenfellner R (1990) Prostatakarzinom: Keine Behandlung -eine Option bei klinisch lokalisiertem Tumor? Aktuel Urol 21: 232–233

    Google Scholar 

  • Voges GE, McNeal JE, Stamey TA (1991) Das inzidentelle Prostatakarzinom: Volumen, Lokalisation und Differenzierungsgrad des Tumors im radikalen Prostatektomie-präparat und Stellenwert der Subklassifikation in ein Stadium AI und A2. Urologe [A] 30: 401–409

    CAS  Google Scholar 

  • Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1992) Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 69: 520–526

    PubMed  CAS  Google Scholar 

  • Ware JL, Maygarden SJ, Koontz WW, Strom SC (1991) Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Hum Pathol 22: 254–258

    PubMed  CAS  Google Scholar 

  • Waring PM, Newland RC (1992) Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic Review. Cancer 69: 755–762

    PubMed  CAS  Google Scholar 

  • Weaver MG, Abdul-Karim FW, Srigley J, Bostwick DG, Ro JY, Ayala AG (1992) Paneth cell-like change of the prostate gland. A histological, immunohistochemical and electron microscopic study. Am J Surg Pathol 16: 62–68

    PubMed  CAS  Google Scholar 

  • Wernert N (1991) Immunhistochemie der Prostata und des Prostatakarzinoms. Fischer, Stuttgart

    Google Scholar 

  • Wernert N, Lüchtrath H, Seeliger H, Schäfer M, Goebbels R, Dohm G (1987) Papillary carcinoma of the prostate localisation and immunhistochemistry. The histogenesis and entity of so-called endometrioid carcinoma. Prostate 10: 123–131

    PubMed  CAS  Google Scholar 

  • Wernert N, Bonkhoff H, Seitz G, Remberger K, Dhom G (1989) Untersuchungen zur Proliferationsaktivität (Ki 67) im normalen, hyperplastischen und karzinomatösen Prostatagewebe. Verh Dtsch Ges Pathol 73: 637

    Google Scholar 

  • Wernert N, Goebbels R, Bonkhoff H, Dhom G (1990) Squamous cell carcinoma of the prostate. Histopathology 17: 339–344

    PubMed  CAS  Google Scholar 

  • Willumsen H, Thorup J, Norgaard T, Hart-Hansen O (1988) Nuclear DNA content in prostatic carcinoma measured by flow cytometry. A retrospective study on paraffin embedded tissue. APMIS [Suppl] 4: 120–125

    CAS  Google Scholar 

  • Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM (1988) Stage Dl prostatic adenocarcinoma: significance of nuclear DNA ploidy pattern studied by flow cytometry. Mayo Clin Proc 63: 103–112

    PubMed  CAS  Google Scholar 

  • Whitmore WF (1990) Locoregional prostatic cancer. Advances in management. Cancer 65: 667–674

    PubMed  Google Scholar 

  • Wood DP, Montie JE, Pontes JE, Levin HS (1989a) Identification of transitional cell carcinoma of the prostate in bladder cancer patients. A prospective study. J Urol 142: 83–85

    PubMed  Google Scholar 

  • Wood DP, Montie JE, Pontes JE, Medendorp SV, Levin HS (1989b) Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol141: 346–349

    PubMed  Google Scholar 

  • Yao JCT, Wang WCC, Tseng HH, Hwang WS (1988) Primary rhabdomyosarcoma of the prostate. Diagnosis by needle biopsy and immunocytochemistry. Acta Cytol (Baltimore) 32: 509–512

    CAS  Google Scholar 

  • Young R, Clement PB (1987) Sclerosing adenosis of the prostate. Arch Pathol Lab Med 111: 363–366

    PubMed  CAS  Google Scholar 

  • Young RH, Frierson Jr HF, Mills SE, Kaiser JS, Talboth WH, Bhan AK (1988/1989) Adenoid cystic-like tumor of the prostate gland: a report of two cases and review of the literature on “adenoid cystic carcinoma” of the prostate. Am J Clin Pathol 88; 89: 49–56

    Google Scholar 

  • Yum M, Miller JC, Agrawal BL (1991) Leiomyosarcoma arising in atypical fibromuscular hyperplasia (phyllodes tumor) of the prostate with distant metastasis. Cancer 68: 910–915

    PubMed  CAS  Google Scholar 

  • Zagars GK, Sherman NE, Babaian RJ (1991) Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer 67: 412–420

    PubMed  CAS  Google Scholar 

  • Zenklusen HR, Weymuth G, Rist M, Mihatsch MJ (1990) Carcinosarcoma of the prostate in combination with adenocarcinoma of the prostate and adenocarcinoma of the seminal vesicles. A case report with immunocytochemical analysis and review of the literature. Cancer 66: 998–1001

    PubMed  CAS  Google Scholar 

  • Zincke H, Blute ML, Fallen MJ, Farrow GM (1991) Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. J Urol 146: 1053–1058

    PubMed  CAS  Google Scholar 

  • Zincke H, Bergstralh EJ, Larson-Keller JJ, Farrow GM, Myers RP, Lieber MM, Barrett DM, Rife CC, Gonchoroff NJ (1992) Stage Dl prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer 70: 311–323

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pathologie, Städtisches Krankenhaus Singen Akademisches Lehrkrankenhaus der Universität Freiburg, Virchowstraße 10, 78224, Singen (Hohentwiel), Deutschland

    Prof. Dr. med. Burkhard Helpap

Authors
  1. Prof. Dr. med. Burkhard Helpap
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Helpap, B. (1993). Tumoren der Prostata. In: Atlas der Pathologie urologischer Tumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77546-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77546-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77547-5

  • Online ISBN: 978-3-642-77546-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation